WellAlly Logo
WellAlly康心伴
EndocrineUpdated on 2026-04-29Medically reviewed

C-Peptide: Normal Range, Results & What They Mean

Everything you need to know about C-Peptide: Normal Range, Results & What They Mean test results, including normal ranges and what abnormal levels might mean.

Reference Range

Unit: ng/mL

Reference Range

Male Reference Range
0.8–3.1 (fasting) ng/mL
Female Reference Range
0.8–3.1 (fasting) ng/mL
i

Reference ranges vary by laboratory. Always consult your healthcare provider for interpretation of your specific results.

What is C-Peptide?

C-peptide is the telltale marker that reveals whether your body is still making its own insulin. When your pancreas produces insulin, it actually creates a larger molecule called proinsulin. This proinsulin splits into two parts: insulin (which lowers blood sugar) and C-peptide (which has no known effect on blood sugar).

Here's why C-peptide is so clever: both insulin and C-peptide are released in equal amounts. But injected insulin (used to treat diabetes) contains no C-peptide. So by measuring C-peptide, doctors can tell the difference between insulin your body produces and insulin you inject.

Think of C-peptide as a receipt that proves your pancreas is still open for business. High C-peptide means your body is making plenty of its own insulin. Low C-peptide means your pancreas has stopped producing insulin. This simple test can distinguish between type 1 and type 2 diabetes, guide treatment decisions, and even reveal hidden insulin-producing tumors.

The Insulin Truth-Teller

C-peptide is the only reliable way to distinguish endogenous insulin production from injected insulin. High C-peptide with high glucose indicates insulin resistance (type 2 diabetes). Low C-peptide with high glucose indicates beta-cell failure (type 1 diabetes). This distinction fundamentally changes treatment approach.

Understanding Your Results

C-peptide is measured in nanograms per milliliter (ng/mL) and should be interpreted with blood glucose levels:

Understanding Your Results (ng/mL)

Optimal
1.0–2.0 (fasting)

Normal endogenous insulin production

Normal
0.8–3.1 (fasting)

Standard range—adequate insulin production

Low
<0.6

Reduced insulin production—possible beta-cell dysfunction

Very Low
<0.3

Severe insulin deficiency—type 1 diabetes likely

High
>3.5

Increased insulin production—insulin resistance or insulinoma

Why C-Peptide Levels Change

C-peptide changes reflect your body's insulin production capacity:

Causes of Abnormal C-Peptide

FactorEffectWhat to Do
Type 1 diabetes (autoimmune beta-cell destruction)DecreasesImmune system destroys insulin-producing beta cells, causing C-peptide to fall. Low or undetectable C-peptide with high glucose confirms type 1 diabetes. Treatment requires lifelong insulin replacement. Early in the disease, some C-peptide may still be present ('honeymoon period').
Type 2 diabetes (insulin resistance)IncreasesBody resists insulin's effects, so pancreas overproduces insulin, raising C-peptide. This is a compensatory response. Early type 2 diabetes shows high C-peptide. As beta cells exhaust from overwork, C-peptide may eventually fall, indicating insulin deficiency.
Insulinoma (insulin-producing tumor)IncreasesRare tumor of pancreatic beta cells that autonomously produces insulin, causing high C-peptide with low glucose. Causes hypoglycemia symptoms. Surgical removal of tumor may be curable. Requires thorough evaluation by endocrinologist.
Advanced type 2 diabetes (beta-cell exhaustion)DecreasesAfter years of overworking to overcome insulin resistance, beta cells may burn out, reducing C-peptide production. This indicates progression to insulin deficiency, requiring insulin therapy. Previously high C-peptide may fall over time.
Sulfonylurea use (stimulates insulin secretion)IncreasesThese diabetes medications stimulate beta cells to release more insulin, raising C-peptide. This is the intended effect. Distinguish from insulinoma by clinical context and medication history. Don't misinterpret as insulin overproduction.

Always tell your doctor about medications, supplements, and recent health events before testing.

The C-Peptide Diagnostic Power

C-peptide helps classify diabetes and guide treatment decisions:

When C-Peptide Patterns Guide Diagnosis

Specific C-peptide patterns, combined with glucose levels, reveal different conditions:

C-Peptide Patterns in Context

C-peptide must always be interpreted with glucose levels and clinical context.

Low C-peptide (<0.5) with high glucose (>126 fasting)

Type 1 diabetes pattern. Pancreas has stopped producing insulin. Requires lifelong insulin replacement. This may be autoimmune type 1 or late-stage type 2 with beta-cell exhaustion. Distinguishing between them guides treatment and prognosis.

High or normal C-peptide with high glucose

Type 2 diabetes pattern. Body is producing insulin but is resistant to its effects. Treatment focuses on insulin sensitizers (metformin), lifestyle changes, and other non-insulin medications initially. Insulin may be needed later if C-peptide declines.

High C-peptide with low glucose (<70)

Insulinoma or excessive medication. Consider insulin-producing tumor or sulfonylurea use. Requires thorough evaluation including imaging studies to locate tumor if present. Surgical removal may be curable for insulinoma.

Normal C-peptide (0.8-3.0) with normal glucose

Normal pattern. No evidence of diabetes or insulin dysfunction. Continue healthy lifestyle to maintain normal glucose metabolism.

Your Action Plan Based on Results

If your C-peptide is normal (0.8-3.1 ng/mL):

  • Adequate insulin production
  • Interpret with glucose levels:
    • Normal glucose: No diabetes present
    • Elevated glucose: Possible insulin resistance (type 2 diabetes)
  • If glucose elevated:
    • Lifestyle modifications (diet, exercise, weight management)
    • May respond to oral diabetes medications
    • Monitor for changes over time

If your C-peptide is low (<0.6 ng/mL):

  • Reduced insulin production
  • Indicates beta-cell dysfunction or destruction
  • Possible causes:
    • Type 1 diabetes (autoimmune)
    • Late-stage type 2 diabetes (beta-cell exhaustion)
    • Pancreatic damage
  • Evaluation may include:
    • Autoantibody testing (GAD65, IA-2, insulin antibodies)
    • Clinical assessment
    • Insulin therapy likely required
  • Endocrinologist consultation recommended

If your C-peptide is high (>3.5 ng/mL):

  • Increased insulin production
  • Interpret with glucose:
    • High glucose: Insulin resistance (type 2 diabetes)
    • Low glucose: Possible insulinoma
  • For high glucose pattern:
    • Focus on insulin sensitization
    • Weight management
    • Exercise and dietary changes
  • For low glucose pattern:
    • Urgent evaluation for insulinoma
    • Review all medications
    • May need imaging studies

The Honeymoon Period

Early in type 1 diabetes, some residual insulin production may continue temporarily ('honeymoon period'), causing C-peptide to be low but not absent. During this time, less insulin may be needed. As honeymoon period ends (typically months to a year), C-peptide becomes undetectable and insulin requirements increase. Serial C-peptide measurements can track this progression."

Common Questions

Track Your C-Peptide Results

Monitor your levels over time, identify trends, and share your history with your doctor.

C-Peptide: Normal Range, Results & What They Mean Test: Normal Range, High/Low Meaning | WellAlly